Contract

Neurodevelopmental Diagnostic Assessments

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

F03: Contract award notice

Notice identifier: 2025/S 000-085020

Procurement identifier (OCID): ocds-h6vhtk-05faa6 (view related notices)

Published 19 December 2025, 3:22pm



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Woodland House, Maes Y Coed Road

Cardiff

CF14 4HH

Contact

Jane Boult

Email

jane.boult@wales.nhs.uk

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://nwssp.nhs.wales/ourservices/procurement-services/

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Neurodevelopmental Diagnostic Assessments

two.1.2) Main CPV code

  • 85121291 - Paediatric services

two.1.3) Type of contract

Services

two.1.4) Short description

Outsourcing of Neurodevelopmental Diagnostic Assessments to reduce waiting lists in Cardiff and Vale University Health Board

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £649,525

two.2) Description

two.2.2) Additional CPV code(s)

  • 85121291 - Paediatric services

two.2.3) Place of performance

NUTS codes
  • UKL22 - Cardiff and Vale of Glamorgan

two.2.4) Description of the procurement

The Cardiff and Vale University Health Board (CAVUHB) Neurodevelopmental Service provides a specialist diagnostic assessment for children and young people with neurodevelopmental disorders. This specialist expertise is provided in the form of assessment and management of children and young people up until the age of 18 years with complex neurodevelopmental disorders. Neurodevelopmental assessments are used to diagnose neurodevelopmental conditions like attention deficit hyperactivity disorder (ADHD) or Autism.

Due to a significant increase in demand, the Health Board is seeking to implement additional clinical resource to undertake appropriate diagnostic assessments for Neurodevelopmental conditions including autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). The additional clinical resource will support in the clinical delivery of diagnostic assessment to children and young people across the age range who have been waiting for assessment for over 2 years

This Notice is an intention to award a contract based on a framework agreement without a competition,

The contract is expected to commence on 6th January 2026, with all identified patients receiving meaningful engagement from the Provider by 31st March 2026. The estimated value of this contract is 649,525.00 GBP based on the identified patient case mix.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 5th January 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

Contract No

CAV-FCONC-(25-26) 169

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

19 December 2025

five.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received from tenderers from other EU Member States: 1

Number of tenders received from tenderers from non-EU Member States: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Healios Limited

Unit 4, Tileyard Studios, Tileyard Road

London

N79AH

Telephone

+44 3301244222

Country

United Kingdom

NUTS code
  • UK - United Kingdom
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £649,525


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 6th January 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales.

Funding has been secured to deliver 377 neurodevelopmental assessments. The Health Board has an established and successful relationship with the proposed supplier and is confident in their ability to mobilise quickly and complete the requirement within the restricted timescales. The award decision makers are relevant staff from Cardiff and Vale University Health Board involved in the provider selection process, these include the roles of General Manager. No conflicts of interest were declared or identified as part of the conflicts assessment process.

The Health Board has decided to make a direct award to the selected provider due to their ability to mobilise quickly and meet the tight timelines required to complete the initial contacts before 31st March 2026.

All providers were considered in the procurement process; however, the Health Board opted to exercise the direct award provision with a previous provider who has successfully delivered similar work under comparable time constraints.

(WA Ref:159677)

six.4) Procedures for review

six.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Telephone

+44 2079477501

Country

United Kingdom